Mexico’s General Prosecution (PGR) was presented last week with a historic charge by the Federal Commission for Economic Competition (COFECE) – the first instance of criminal charges filed over monopolistic practices, which affected he purchase of various public sector institutions.
The charges state that the illegal sale procedure implied “serious damage to the Healthcare sector, as the resources acquired directly affect the services provided by the State to the general population.”
The agency added that they have collected evidence of collusion between several bidders for public contracts in the health sector allocated between 2009 and 2015, affecting the acquisition of resources for various public health institutions worth over $1.2 billion pesos.
Full Content: Proceso
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Netflix and Other Streaming Giants Challenge Canadian Rules on News Funding
Jul 7, 2024 by
CPI
Watchdog Urges Colorado Investigation into Potential Rent Price Collusion
Jul 7, 2024 by
CPI
Antitrust Battle Looms Over Apple’s Lucrative Safari Deal with Google
Jul 7, 2024 by
CPI
Zimbrón Rejoins Cleary Gottlieb Steen & Hamilton as Antitrust Partner in London
Jul 7, 2024 by
CPI
NFL Petitions Judge to Overturn $4.7 Billion ‘Sunday Ticket’ Verdict
Jul 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI